US drugmakers have almost 200 medicines in development for mental illnesses
10:08 EDT 15 Jul 2012 | thePharmaLetter
Research-based biopharmaceutical companies in the USA are developing 187 innovative medicines to help the nearly 60 million patients in the country who are suffering from some form of mental illness, excluding Alzheimer's disease, for which a separat..
Original Article: US drugmakers have almost 200 medicines in development for mental illnesses
More From BioPortfolio on "US drugmakers have almost 200 medicines in development for mental illnesses"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
